Herombopag Olamine in the Treatment of Thrombocytopenia After Chemotherapy
To evaluate the efficacy and safety of hetrombopag in the treatment of thrombocytopenia after chemotherapy in patients with digestive system malignant tumors
Malignant Tumors of the Digestive System|Trombocitopenia
DRUG: Hetrombopag Olamine
Days required for platelet recovery to ≥75×10^9/ L, Days required for platelet recovery to ≥75×10\^9/ L, At the end of Cycle 1 (each cycle is 28 days)
The lowest platelet count, The lowest platelet count, At the end of Cycle 2 (each cycle is 28 days)|Safety of treatment, Measure of time from study enrollment until progression., 2 Cycle (each cycle is 28 days)
To evaluate the efficacy and safety of hetrombopag in the treatment of thrombocytopenia after chemotherapy in patients with digestive system malignant tumors